login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
EXACT SCIENCES CORP (EXAS) Stock News
NASDAQ:EXAS -
US30063P1057
-
Common Stock
45.66
USD
-1.81 (-3.81%)
Last: 8/25/2025, 8:17:09 PM
45.9
USD
+0.24 (+0.53%)
After Hours:
8/25/2025, 8:17:09 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
EXAS Latest News, Press Relases and Analysis
All
Press Releases
19 days ago - By: Chartmill
- Mentions:
ULBI
MEG
TPC
FTNT
...
Discover the top movers in Thursday's pre-market session.
19 days ago - By: Chartmill
- Mentions:
TPC
CREG
TNDM
ARIS
...
Stay updated with the stocks that are on the move in today's after-hours session.
7 days ago - By: Exact Sciences Corp.
Exact Sciences to Participate in September Investor Conferences
11 days ago - By: Zacks Investment Research
- Mentions:
TMO
ILMN
GH
TMO Receives FDA Approval for Oncomine Dx Target Test
13 days ago - By: Zacks Investment Research
- Mentions:
GH
TEM
TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?
13 days ago - By: Benzinga
- Mentions:
BLDP
SMRT
ENB
MU
...
Micron To Rally More Than 49%? Here Are 10 Top Analyst Forecasts For Tuesday
14 days ago - By: Zacks Investment Research
- Mentions:
BSX
MEDP
WGS
EXAS Stock Dips Despite Q2 Earnings & Revenue Beat, '25 Sales View Up
14 days ago - By: The Motley Fool
- Mentions:
TTD
PINS
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
14 days ago - By: Zacks Investment Research
Here's Why Exact Sciences (EXAS) is a Strong Growth Stock
15 days ago - By: Benzinga
Beyond The Numbers: 7 Analysts Discuss Exact Sciences Stock
17 days ago - By: Zacks Investment Research
- Mentions:
AZN
IRWD
ABBV
IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates
17 days ago - By: Zacks Investment Research
- Mentions:
PBYI
CRMD
IMCR
PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues
19 days ago - By: Zacks Investment Research
- Mentions:
VTGN
Exact Sciences (EXAS) Surpasses Q2 Earnings and Revenue Estimates
19 days ago - By: The Motley Fool
Exact Sciences (EXAS) Q2 Revenue Up 16%
19 days ago - By: Investor's Business Daily
How Exact Sciences Is Spending $775 Million To Dominate The Cancer-Screening Market
19 days ago - By: Exact Sciences Corp.
Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests
19 days ago - By: Exact Sciences Corp.
Exact Sciences Announces Second Quarter 2025 Results
21 days ago - By: Zacks Investment Research
- Mentions:
FHTX
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates
21 days ago - By: Zacks Investment Research
- Mentions:
PFE
AMRX
VTRS
Viatris Poised to Report Q2 Earnings: What's in Store for the Stock?
24 days ago - By: Zacks Investment Research
- Mentions:
ZTS
BNTX
Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect
25 days ago - By: Zacks Investment Research
- Mentions:
CAH
COR
STE
Will Healthcare Growth Help STE Beat on Q1 Earnings?
26 days ago - By: Yahoo Finance
Will Exact Sciences Corporation (EXAS) Continue to Penetrate the Market with Its Cologuard Test?
26 days ago - By: Exact Sciences Corp.
Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test
Please enable JavaScript to continue using this application.